In a recent study posted to the bioRxiv* pre-print server, researchers in the United States described a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody ...
A research team collaborating across the University of Texas Medical Branch-Galveston, Pfizer Vaccine Research, and BioNTech SE recently conducted a study on the neutralization capacity of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback